Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation Long Term Debt 2017–2025
Adaptive Biotechnologies Corporation annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Adaptive Biotechnologies Corporation long term debt as of December 31, 2025: 126.6M, a 4.42% decrease year-over-year.
- Adaptive Biotechnologies Corporation long term debt for 2025 were 126.6M, a 4.42% decrease from 2024.
- Adaptive Biotechnologies Corporation long term debt for 2024 were 132.4M, a 1.34% increase from 2023.
- Adaptive Biotechnologies Corporation long term debt for 2023 were 130.7M, a 4.23% increase from 2022.
- Adaptive Biotechnologies Corporation long term debt for 2022 were 125.4M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Adaptive Biotechnologies Corporation Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $127 |
| 2024 | $132 |
| 2023 | $131 |
| 2022 | $125 |
Adaptive Biotechnologies Corporation Long Term Debt — FAQ
Adaptive Biotechnologies Corporation (ADPT) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADPT's long term debt history?
The chart and table above show Adaptive Biotechnologies Corporation's long term debt by year and by quarter, including the growth rate.